References
- Pelletier J, Haber D A, Housman D E. Genetics of Wilms' tumor. Origins of Human Cancer: A Comprehensive Review, J Brugge, T Curran, E Harlow, F McCormick. Cold Spring Harbor Press, Plainview, NY 1991; 433–41
- Reeve A E, Eccles M R, Wilkins R J. Expression of insulin-like growth factor-II transcripts in Wilms' tumor. Nature 1985; 317: 258–60
- Scott J, Cowell J, Robertson M E. Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature 1985; 317: 260–2
- Gansler T, Allen K D, Burant C F. Detection of type 1 insulinlike growth factor (IGF) receptors in Wilms' tumors. Am J Pathol 1988; 130: 431–5
- Gansler T, Furlanetto R, Gramling T S. Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice. Am J Pathol 1989; 135: 961–6
- Clemmons D R. IGF binding proteins: Regulation of cellular actions. Growth Reg 1992; 2: 80–7
- Garvin A J, Sullivan J L, Bennett D D. The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor. Am J Pathol 1987; 129: 353–63
- Garvin A J, Surrette F, Hintz D S. The in vitro growth and characterization of the skeletal muscle component of Wilms' tumor. Am J Pathol 1985; 121: 298–310
- Hazen-Martin D J, Garvin A J, Gansler T. Morphology and growth characteristics of epithelial cells from classic Wilms' tumors. Am J Pathol 1993; 142: 893–905
- Hossenlopp P, Seurin D, Segovia-Quinson B. Analysis of serum insulin-like growth factor binding proteins using western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986; 154: 138–43
- Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–9
- Zapf J, Kiefer M, Merryweather J. Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia. J Biol Chem 1990; 265: 14892–8
- Camacho-Hubner C, Busby W H, McCusker R H. Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem 1992; 267: 11949–56
- Drummond I A, Madden S L, Rohwer-Nutter P. Repression of the insulin-like growth factor II gene by the Wilms' tumor suppressor WT1. Science 1992; 257: 674–8
- Call K M, Glaser T, Ito C Y. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990; 60: 509–20
- Rauscher F J, Morris J F, Tournay O E. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 1990; 250: 1259–62
- De Pagter-Holthuizen P, Jansen M, Van Schaik FM A. The human insulin-like growth factor II gene contains two development-specific promoters. FEBS Lett 1987; 214: 259–64
- Ehrenborg E, Vilhelmsdotter S, Bajalica S. Structure and localization of the human insulin-like growth factor-binding protein 2 gene. Biochem Biophys Res Commun 1991; 176: 1250–5
- Brown A L, Rechler M M. Cloning of the rat insulin-like growth factor-binding protein-2 gene and identification of a functional promoter lacking a TATA box. Mol Endocrinol 1990; 12: 2039–51
- Ross M, Francis G L, Szabo L. Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1–3)-IGF-1. Biochem J 1989; 258: 267–72
- Schofield P N, Lee A, Hill D J. Tumour suppression associated with expression of human insulin-like growth factor II. Br J Cancer 1991; 63: 687–92
- Florini J R, Magri K A, Ewton D Z. “Spontaneous” differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 1991; 266: 15917–23
- Tollefsen S E, Lajara R, McCusker R H. Insulin-like growth factors (IGF) in muscle development. J Biol Chem 1989; 264: 13810–7